Among these patients, 53 samples (70.7%) harbored mutant p53 protein expression which correlated with more distant metastasis (Table 1) and poor overall survival of patients with colorectal adenocarcinomas (Fig. 1b). Here, TP53 is linked to colorectal adenocarcinoma.